These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 16868944

  • 1. Treating hepatitis C infection in liver transplant recipients.
    Terrault NA, Berenguer M.
    Liver Transpl; 2006 Aug; 12(8):1192-204. PubMed ID: 16868944
    [Abstract] [Full Text] [Related]

  • 2. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.
    Clin Transplant; 2006 Aug; 20(6):677-83. PubMed ID: 17100715
    [Abstract] [Full Text] [Related]

  • 3. Chronic hepatitis C and liver transplantation.
    Davis GL.
    Rev Gastroenterol Disord; 2004 Aug; 4(1):7-17. PubMed ID: 15029106
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of recurrent hepatitis C infection after liver transplantation].
    Filipec Kanizaj T, Colić Cvrlje V, Mrzljak A, Ostojić R.
    Acta Med Croatica; 2009 Dec; 63(5):451-7. PubMed ID: 20198907
    [Abstract] [Full Text] [Related]

  • 5. Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.
    Riediger C, Berberat PO, Sauer P, Gotthardt D, Weiss KH, Mehrabi A, Merle U, Stremmel W, Encke J.
    Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii37-viii46. PubMed ID: 17890261
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of chronic hepatitis C].
    Rókusz L.
    Orv Hetil; 2004 Aug 08; 145(32):1649-53. PubMed ID: 15384863
    [Abstract] [Full Text] [Related]

  • 7. Management of chronic hepatitis C.
    Asselah T, Boyer N, Ripault MP, Martinot M, Marcellin P.
    Minerva Gastroenterol Dietol; 2007 Mar 08; 53(1):9-23. PubMed ID: 17415342
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
    Roche B, Sebagh M, Canfora ML, Antonini T, Roque-Afonso AM, Delvart V, Saliba F, Duclos-Vallee JC, Castaing D, Samuel D.
    Liver Transpl; 2008 Dec 08; 14(12):1766-77. PubMed ID: 19025933
    [Abstract] [Full Text] [Related]

  • 9. Treatment of recurrent hepatitis C after liver transplantation.
    Biggins SW, Terrault NA.
    Clin Liver Dis; 2005 Aug 08; 9(3):505-23, ix. PubMed ID: 16023980
    [Abstract] [Full Text] [Related]

  • 10. Review article: the treatment of hepatitis C virus recurrence after liver transplantation.
    Arjal RR, Burton JR, Villamil F, Rosen HR.
    Aliment Pharmacol Ther; 2007 Jul 15; 26(2):127-40. PubMed ID: 17593060
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis C therapy before and after liver transplantation.
    Terrault NA.
    Liver Transpl; 2008 Oct 15; 14 Suppl 2():S58-66. PubMed ID: 18825697
    [Abstract] [Full Text] [Related]

  • 12. Should patients with chronic hepatitis C infection be transplanted?
    Botero RC.
    Transplant Proc; 2004 Jun 15; 36(5):1449-54. PubMed ID: 15251356
    [Abstract] [Full Text] [Related]

  • 13. [The course of hepatitis C infection after liver transplantation].
    Ołdakowska-Jedynak U, Paczek L.
    Pol Merkur Lekarski; 2005 Aug 15; 19(110):220-4. PubMed ID: 16245439
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis C.
    Burra P.
    Semin Liver Dis; 2009 Feb 15; 29(1):53-65. PubMed ID: 19235659
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis C virus in the transplant setting.
    Berenguer M, Wright TL.
    Antivir Ther; 1998 Feb 15; 3(Suppl 3):125-36. PubMed ID: 10726062
    [Abstract] [Full Text] [Related]

  • 16. Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence.
    Sharma P, Marrero JA, Fontana RJ, Greenson JK, Conjeevaram H, Su GL, Askari F, Sullivan P, Lok AS.
    Liver Transpl; 2007 Aug 15; 13(8):1100-8. PubMed ID: 17377914
    [Abstract] [Full Text] [Related]

  • 17. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
    Yu ML, Lin SM, Chuang WL, Dai CY, Wang JH, Lu SN, Sheen IS, Chang WY, Lee CM, Liaw YF.
    Antivir Ther; 2006 Aug 15; 11(8):985-94. PubMed ID: 17302368
    [Abstract] [Full Text] [Related]

  • 18. The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment.
    Terrault NA, Adey DB.
    Clin J Am Soc Nephrol; 2007 May 15; 2(3):563-75. PubMed ID: 17699464
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R.
    Acta Med Croatica; 2005 May 15; 59(5):443-6. PubMed ID: 16381241
    [Abstract] [Full Text] [Related]

  • 20. Current and future management of chronic hepatitis C infection.
    Cross TJ, Antoniades CG, Harrison PM.
    Postgrad Med J; 2008 Apr 15; 84(990):172-6. PubMed ID: 18424572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.